| Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies F Catalá-López, M Suárez-Pinilla, P Suárez-Pinilla, JM Valderas, ... Psychotherapy and psychosomatics 83 (2), 89-105, 2014 | 223 | 2014 |
| Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset MK Chan, MO Krebs, D Cox, PC Guest, RH Yolken, H Rahmoune, ... Translational psychiatry 5 (7), e601-e601, 2015 | 184 | 2015 |
| Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium E Walton, DP Hibar, TGM Van Erp, SG Potkin, R Roiz-Santiañez, ... Psychological medicine 48 (1), 82-94, 2018 | 151 | 2018 |
| Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium E Walton, DP Hibar, TGM van Erp, SG Potkin, R Roiz‐Santiañez, ... Acta Psychiatrica Scandinavica 135 (5), 439-447, 2017 | 99 | 2017 |
| Homocysteine and cognition: A systematic review of 111 studies E Setién-Suero, M Suárez-Pinilla, P Suárez-Pinilla, B Crespo-Facorro, ... Neuroscience & Biobehavioral Reviews 69, 280-298, 2016 | 78 | 2016 |
| Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies—PSYSCAN: translating neuroimaging findings from research into clinical practice S Tognin, HH van Hell, K Merritt, I Winter-van Rossum, MG Bossong, ... Schizophrenia bulletin 46 (2), 432-441, 2020 | 70 | 2020 |
| Immune system: a possible nexus between cannabinoids and psychosis P Suárez-Pinilla, J López-Gil, B Crespo-Facorro Brain, behavior, and immunity 40, 269-282, 2014 | 69 | 2014 |
| Gene-environment interactions underlying the effect of cannabis in first episode psychosis J Maria Pelayo-Teran, P Suárez-Pinilla, N Chadi, B Crespo-Facorro Current pharmaceutical design 18 (32), 5024-5035, 2012 | 69 | 2012 |
| Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone … M Gómez-Revuelta, JM Pelayo-Terán, M Juncal-Ruiz, ... International Journal of Neuropsychopharmacology 23 (4), 217-229, 2020 | 67 | 2020 |
| In-and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised … B Fernández-Abascal, P Suárez-Pinilla, C Cobo-Corrales, ... Neuroscience & Biobehavioral Reviews 125, 535-568, 2021 | 61 | 2021 |
| Brain structural effects of antipsychotic treatment in schizophrenia: a systematic review R Roiz-Santiañez, P Suarez-Pinilla, B Crespo-Facorro Current neuropharmacology 13 (4), 422-434, 2015 | 56 | 2015 |
| Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment J Tomasik, SG Lago, J Vázquez-Bourgon, S Papiol, P Suárez-Pinilla, ... JAMA psychiatry 76 (8), 864-867, 2019 | 53 | 2019 |
| Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis JM Pelayo-Terán, FJ Diaz, R Pérez-Iglesias, P Suarez-Pinilla, ... Psychological medicine 44 (1), 37-50, 2014 | 46 | 2014 |
| Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study B Crespo-Facorro, VOG de la Foz, R Ayesa-Arriola, R Pérez-Iglesias, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, 162-167, 2013 | 46 | 2013 |
| Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables I Díaz, JM Pelayo-Terán, R Pérez-Iglesias, I Mata, R Tabarés-Seisdedos, ... Psychiatry Research 206 (2-3), 181-187, 2013 | 45 | 2013 |
| Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms P Suárez-Pinilla, R Roiz-Santiañez, VOG de la Foz, PC Guest, ... Psychiatry Research: Neuroimaging 233 (2), 112-119, 2015 | 42 | 2015 |
| Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis R Pérez-Iglesias, VOG de la Foz, OM García, JA Amado, ... Schizophrenia research 159 (1), 90-94, 2014 | 41 | 2014 |
| Understanding sex differences in long-term outcomes after a first episode of psychosis R Ayesa-Arriola, VOG de la Foz, E Setién-Suero, ML Ramírez-Bonilla, ... Npj Schizophrenia 6 (1), 33, 2020 | 40 | 2020 |
| Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment M Juncal-Ruiz, M Ramirez-Bonilla, J Gomez-Arnau, ... Psychopharmacology 234, 2563-2570, 2017 | 40 | 2017 |
| Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naive patients with a first-episode of non-affective psychosis J Vázquez-Bourgon, R Pérez-Iglesias, V Ortiz-Garcia de la Foz, ... Psychopharmacology 235, 245-255, 2018 | 38 | 2018 |
